| Administration, distribution, metabolism and elimination of polymer therapeutics E Markovsky, H Baabur-Cohen, A Eldar-Boock, L Omer, G Tiram, S Ferber, ... Journal of controlled release 161 (2), 446-460, 2012 | 390 | 2012 |
| Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators J Conniot, A Scomparin, C Peres, E Yeini, S Pozzi, AI Matos, R Kleiner, ... Nature nanotechnology 14 (9), 891-901, 2019 | 195 | 2019 |
| Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery A Scomparin, S Salmaso, S Bersani, R Satchi-Fainaro, P Caliceti European Journal of Pharmaceutical Sciences 42 (5), 547-558, 2011 | 128 | 2011 |
| Nano-sized polymers and liposomes designed to deliver combination therapy for cancer A Eldar-Boock, D Polyak, A Scomparin, R Satchi-Fainaro Current opinion in biotechnology 24 (4), 682-689, 2013 | 127 | 2013 |
| Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy Z Shatsberg, X Zhang, P Ofek, S Malhotra, A Krivitsky, A Scomparin, ... Journal of Controlled Release 239, 159-168, 2016 | 110 | 2016 |
| Direct real‐time monitoring of prodrug activation by chemiluminescence S Gnaim, A Scomparin, S Das, R Blau, R Satchi‐Fainaro, D Shabat Angewandte Chemie 130 (29), 9171-9175, 2018 | 103 | 2018 |
| Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation AL Silva, C Peres, J Conniot, AI Matos, L Moura, B Carreira, V Sainz, ... Seminars in immunology 34, 3-24, 2017 | 97 | 2017 |
| A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index A Scomparin, S Salmaso, A Eldar-Boock, D Ben-Shushan, S Ferber, ... Journal of controlled release 208, 106-120, 2015 | 96 | 2015 |
| Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome S Ferber, G Tiram, A Sousa-Herves, A Eldar-Boock, A Krivitsky, ... Elife 6, e25281, 2017 | 83 | 2017 |
| Inflammatory activation of astrocytes facilitates melanoma brain tropism via the CXCL10-CXCR3 signaling axis H Doron, M Amer, N Ershaid, R Blazquez, O Shani, TG Lahav, N Cohen, ... Cell reports 28 (7), 1785-1798. e6, 2019 | 80 | 2019 |
| Overcoming obstacles in microRNA delivery towards improved cancer therapy D Ben-Shushan, E Markovsky, H Gibori, G Tiram, A Scomparin, ... Drug delivery and translational research 4, 38-49, 2014 | 73 | 2014 |
| Light emission enhancement by supramolecular complexation of chemiluminescence probes designed for bioimaging S Gnaim, A Scomparin, A Eldar-Boock, CR Bauer, R Satchi-Fainaro, ... Chemical science 10 (10), 2945-2955, 2019 | 67 | 2019 |
| Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer AI Matos, B Carreira, C Peres, LIF Moura, J Conniot, T Fourniols, ... Journal of Controlled Release 307, 108-138, 2019 | 60 | 2019 |
| Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins R Blau, Y Epshtein, E Pisarevsky, G Tiram, SI Dangoor, E Yeini, ... Theranostics 8 (13), 3437, 2018 | 60 | 2018 |
| Achieving successful delivery of oligonucleotides — From physico-chemical characterization to in vivo evaluation A Scomparin, D Polyak, A Krivitsky, R Satchi-Fainaro Biotechnology advances 33 (6), 1294-1309, 2015 | 54 | 2015 |
| Nanosponges as protein delivery systems: Insulin, a case study SL Appleton, M Tannous, M Argenziano, E Muntoni, AC Rosa, D Rossi, ... International Journal of Pharmaceutics 590, 119888, 2020 | 51 | 2020 |
| Interfering cancer with polymeric siRNA nanomedicines G Tiram, A Scomparin, P Ofek, R Satchi-Fainaro Journal of biomedical nanotechnology 10 (1), 50-66, 2014 | 51 | 2014 |
| Novel pullulan bioconjugate for selective breast cancer bone metastases treatment G Bonzi, S Salmaso, A Scomparin, A Eldar-Boock, R Satchi-Fainaro, ... Bioconjugate chemistry 26 (3), 489-501, 2015 | 50 | 2015 |
| Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? S Pozzi, A Scomparin, SI Dangoor, DR Ajamil, P Ofek, L Neufeld, ... Advanced Drug Delivery Reviews 175, 113760, 2021 | 49 | 2021 |
| Two-step polymer-and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives A Scomparin, HF Florindo, G Tiram, EL Ferguson, R Satchi-Fainaro Advanced drug delivery reviews 118, 52-64, 2017 | 40 | 2017 |
